Crizotinib trials for Lung cancer

All Crizotinib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Crizotinib for Lung cancer

• A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
  NCT06564324 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 29 locations
• ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma
  NCT05014464 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.
  NCT06563999 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Crizotinib for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.